rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

BROADWOOD PARTNERS, L.P.

10% owner

Company insider

Files Form 4 as: 10% owner, Insight Molecular Diagnostics; Director and 10% owner, STAAR Surgical; Director and 10% owner, Lineage Cell Therapeutics; Other, Asterias Biotherapeutics; 10% owner, Comarco; Director, Questcor Pharmaceuticals; 10% owner, Palomar Medical Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
443
Buys
106
Sells
9
Bought
$138.9M
Sold
$60.8M
Companies
7
Companies where not an officer
7
First trade
9 Jan 2007
Last trade
27 Apr 2026
Last filed
27 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMDX Insight Molecular Diagnostics10% owner · Diagnostics & Labs · last 27 Apr 202613 buys · 0 sells
STAA STAAR SurgicalDirector, 10% owner · Medical Devices · last 13 Mar 202657 buys · 6 sells
LCTX Lineage Cell TherapeuticsDirector, 10% owner · Biotechnology · last 6 Feb 20249 buys · 1 sell
Asterias BiotherapeuticsOther · last 16 Oct 20171 buy · 0 sells
Comarco10% owner · last 11 Sep 201721 buys · 0 sells
Questcor PharmaceuticalsDirector · last 14 Aug 20140 buys · 2 sells
Palomar Medical Technologies10% owner · last 24 Jun 20135 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
06Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$913K250,923 at $3.64filing
27 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
27 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$913K250,923 at $3.64filing
27 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
24 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$137K38,880 at $3.53filing
24 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
24 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$137K38,880 at $3.53filing
24 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
23 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$982K280,381 at $3.50filing
23 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
23 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$981K280,381 at $3.50filing
23 Apr 2026filed 27 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
20 Apr 2026filed 20 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$158K40,690 at $3.88filing
20 Apr 2026filed 20 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
17 Apr 2026filed 20 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$143K40,114 at $3.57filing
17 Apr 2026filed 20 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
16 Apr 2026filed 20 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought$352K102,057 at $3.45filing
16 Apr 2026filed 20 Apr 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Bought—0 at $0.00filing
13 Mar 2026filed 13 Mar 2026STAA STAAR SurgicalMedical DevicesSEC FORM 4 Bought$5.9M316,017 at $18.62filing
13 Mar 2026filed 13 Mar 2026STAA STAAR SurgicalMedical DevicesSEC FORM 4 Bought—0 at $0.00filing

Sectors

Health Care86
Not placed29

Buys in green, sells in red, by the company’s sector.

Related people

Deborah J. AndrewsChief Financial Officer & EVP · Chief Financial Officer & EVP at Staar Surgical Co, filing Form 4 there in the last year
Warren FoustPresident and CEO · President and CEO at Staar Surgical Co, filing Form 4 there in the last year
Magda MichnaChief Development Officer · Chief Development Officer at Staar Surgical Co, filing Form 4 there in the last year
Lou SilvermanDirector · Director at Insight Molecular Diagnostics, filing Form 4 there in the last year
Andrew J. LastDirector · Director at Insight Molecular Diagnostics, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded STAA in the last 90 days